Alligator-FAB consists of a variety of antibody strains that can be used to generate pools of antibody variants, it said. It complements the company's existing Alligator-Gold and Alligator-Ruby libraries, according to the firm, and has been important to the development of the company's latest novel immune-oncology drug candidate, Neo-X-Prime.

Antibody fragments may be exceptionally effective against SARS-CoV-2
An engineered antibody fragment has been developed as a highly potent neutralizer of SARS-CoV-2. For the first time, one of these tiny molecules has been...

Twist Bioscience, Seismic Bio partner to discover bispecific antibodies
Twist Bioscience and Seismic Bio have formed a partnership to discover and optimize antibodies to high-value immuno-oncology targets.

Alligator, Scandion pursue preclinical immunotherapies
Sweden-based Alligator Bioscience and Scandion Oncology inked an agreement to explore the antitumor efficacy of CD40 antibody mitazalimab in combination...